Leyla Sahin, MD

Deputy Director for Safety
US Food and Drug Administration
Silver Spring, Maryland, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• Post-authorization Regulatory Strategies to Evaluate Drug Safety in Pregnancy: How to Optimize the Design of Registries & Database Studies

  Friday, August 26, 2022
  10:30 AM – 12:00 PM CEST

• Characteristics and Medication Use Patterns of Pregnancies with COVID-19 in the Sentinel System

  Friday, August 26, 2022
  2:45 PM – 3:00 PM CEST